This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Plexxikon Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Xinping Han
Introduction
Xinping Han is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of CD73. His work has implications for various therapeutic applications.
Latest Patents
Xinping Han holds a patent titled "Compounds and methods for CD73 modulation and indications therefor." This patent discloses compounds capable of modulating CD73, including a pharmaceutically acceptable salt, a solvate, a tautomer, a stereoisomer, or a deuterated analog thereof. The patent outlines the specific formula and compositions that can be utilized for therapeutic purposes.
Career Highlights
Xinping Han is currently employed at Plexxikon Inc., where he continues to innovate in the field of drug development. His expertise in CD73 modulation has positioned him as a key figure in advancing therapeutic strategies.
Collaborations
He has collaborated with notable colleagues such as Mark Vander Wal and John Buell, contributing to a dynamic research environment that fosters innovation.
Conclusion
Xinping Han's work exemplifies the intersection of scientific research and practical application in pharmaceuticals. His contributions to CD73 modulation are paving the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile